Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Presence of Docetaxel in Patients With HER2-Positive Metastatic or Locally Advanced Inoperable Cancer
This study has been completed.
Study NCT00927589   Information provided by Genentech

First Received on June 24, 2009.   Last Updated on June 5, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Cancers
Additional conditions recognized in this trial
Neoplasm Metastasis
More general conditions related to this trial
Neoplasms
Neoplastic Processes
Pathologic Processes
Interventions listed in this trial
carboplatin
docetaxel
trastuzumab
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Genentech


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services